More News

Frascati Manual 2015 - Guidelines for Collecting and Reporting Data on Research and Experimental Development

Big Data for Advancing Dementia Research - An Evaluation of Data Sharing Practices in Research on Age-related Neurodegenerative Diseases

Dementia is increasing in prevalence, and to date has no cure or treatment. One element in improving this situation is using and sharing data more widely to increase the power of research. Further, moving beyond established medical data into big data offers the potential to tap into routinely collected data from both within and outside the health system.

Biobased Chemicals and Bioplastics: Finding the Right Policy Balance

Several OECD countries have published their plans for the development of a future bioeconomy, in which bio-based materials and production techniques will contribute significantly to economic and environmental sustainability. The case for support for bio-based chemicals and plastics therefore warrants serious attention.

Emerging Policy Issues in Synthetic Biology

Synthetic biology is an emerging technology that shows promise for investigating some of the burning issues in biological research. It also has the potential to address some of the grand challenges facing society, such as climate change and energy security.

Unleashing the Power of Big Data for Alzheimer's Disease and Dementia Research

More than 35 million people worldwide had dementia in 2010 and this number is expected to exceed 115 million by 2050. This paper reports on the opportunities offered by the informatics revolution and big data to address Alzheimer’s Disease and dementia. This will require careful planning and multi-stakeholder collaboration as technical, administrative, regulatory, infrastructure and financial obstacles emerge.

Workshop on Integrating Omics and Policy for Healthy Ageing: Synthesis Report

An ageing population brings new challenges both to healthcare systems and to medicine in terms of the increased manifestation of specific diseases primarily seen in the elderly. Biomedical innovation, and in particular research into "omics technologies", offers the promise of new means of detection, prevention and treatment of age-related disabilities and diseases.

Policies for Bioplastics in the Context of a Bioeconomy

This paper explores the development of the bioplastics sector and its role in national bioeconomy strategies. It finds that bioplastics are at a disadvantage compared to some other biobased products, notably biofuels, that often benefit from preferential treatment. It also notes that greater efforts are needed at the international level as regards standards to avoid creating barriers to international trade in biobased products.

Public Health in an Age of Genomics

This report presents the findings of a research project to investigate the drivers and criteria shaping the application of genomic biotechnology to health in different national settings, and the barriers to implementation nationally and internationally. Findings are based on case studies on Finland, Israel, Luxembourg, Mexico, the United Kingdom, China and South Africa.

Emerging Trends in Biomedicine and Health Technology Innovation: Addressing the Global Challenge of Alzheimer's

The economic and social impact of chronic brain disorders such as Alzheimer’s and other neurodegenerative diseases will become the #1 public health problem worldwide by 2050, directly affecting 100 million people. Ongoing demographic trends, namely ageing populations, are leading to the unprecedented expansion of consumer demand for healthcare services, which will confront a serious crisis in a climate of shrinking resources.

Nanotechnology for Green Innovation

This paper brings together information collected through Working Party on Nanotechnology discussions and projects. It relies in particular on preliminary results from a project on the responsible development of nanotechnology and outcomes of a symposium held in 2012.